Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on Alteryx, Raises Price Target to $68

Needham analyst Mike Cikos maintains Alteryx (NYSE:AYX) with a Buy and raises the price target from $57 to $68.

byBenzinga Newsdesk

August 3, 2022

1 minute read

Needham analyst Mike Cikos maintains Alteryx (NYSE:AYX) with a Buy and raises the price target from $57 to $68.

Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson’s Disease

By Vuk Zdinjak

Today, 6:48 AM

Gb Sciences, Inc. (OTCQB: GBLX) has selected the University of Lethbridge in Canada to complete a dose range study of Gb Sciences' patent-protected formulations in a rodent model of Parkinson's disease. The company plans on filing an investig

GBLX

News

5 Value Stocks In The Basic Materials Sector

By Benzinga Insights

Today, 6:48 AM

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.